RCKT ROCKET PHARMACEUTICALS INC US FDA Inspections 8-K Filing 2023 - FDA Designation for Gene Therapy Rocket Pharmaceuticals, Inc. announced that the U.S. FDA granted a Regenerative Medicine Advanced Therapy (RMAT) designation for its investigational gene therapy for Danon Disease.Get access to all SEC 8-K filings of the ROCKET PHARMACEUTICALS INC